PCN43 COST-EFFECTIVENESS OF CETUXIMAB (ERBITUX®) IN COMBINATION WITH RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN THE TREATMENT OF LOCALLY ADVANCED HEAD AND NECK CANCER IN FRANCE
Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63473-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)63473-0/fulltext
Title :
PCN43 COST-EFFECTIVENESS OF CETUXIMAB (ERBITUX®) IN COMBINATION WITH RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN THE TREATMENT OF LOCALLY ADVANCED HEAD AND NECK CANCER IN FRANCE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63473-0&doi=10.1016/S1098-3015(10)63473-0
First page :
Section Title :
Open access? :
No
Section Order :
326